Phase I Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib With Concurrent Radiotherapy for Advanced Head and Neck Cancer-Reference-Cited by-同舟云学术

Phase I Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib With Concurrent Radiotherapy for Advanced Head and Neck Cancer

Published:2018-05 Issue:5 Volume:41 Page:441-446
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Ahn Peter H.,Machtay Mitchell,Anne Pramila R,Cognetti David,Keane William M.,Wuthrick Evan,Dicker Adam P.,Axelrod Rita S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference31 articles.

1. Trends in incidence and prognosis for head and neck cancer in the united states: a site-specific analysis of the SEER database;Carvalho;Int J Cancer,2005

2. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma;Calais;J Natl Cancer Inst,1999

3. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer;Forastiere;N Engl J Med,2003

4. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer;Brizel;N Engl J Med,1998

5. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck;Adelstein;Cancer,2000

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and tolerability of radiotherapy in combination with systemic targeted therapies for treatment of hepatocellular carcinoma: a narrative review;Chinese Clinical Oncology;2024-06

2. Dual effects of radiotherapy on tumor microenvironment and its contribution towards the development of resistance to immunotherapy in gastrointestinal and thoracic cancers;Frontiers in Cell and Developmental Biology;2023-10-03

3. Molecular and biological factors in the prognosis of head and neck squamous cell cancer;Molecular Biology Reports;2023-07-26

4. A Review of Advances in Radiotherapy in the Setting of Esophageal Cancers;Surgical Oncology Clinics of North America;2023-07

5. A review of efficacy and safety of cetuximab and bevacizumab-based monoclonal antibodies in head and neck cancer;Medical Oncology;2022-12-30